Pierrel. Company, history, milestones
Italian innovation and quality for the oral health industry
ABOUT US
Pierrel is a global player in the pharmaceutical market, with over 70 years of experience in the field of oral care and listed at Euronext Milan of Borsa Italiana.
Pierrel is a global player in the pharmaceutical market, with over 70 years of experience in the field of oral care and listed at Euronext Milan of Borsa Italiana.
Our legal and operational headquarters are in Capua, near Caserta and a few kilometers from Naples. The production facility received the first authorizations from the European Medicines Agency (EMA) in 1989 and from the Food and Drug Administration (FDA) in 2009 for the aseptic production of injectable drugs. Over the years, the core of our activity has been focused on the registration and marketing of dental anesthetics with Pierrel brand; including Orabloc,
registered in the major international markets (including USA, Canada, Italy, Russia, Poland, Serbia, France, UK, Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia). Today, thanks to the FDA’s approval, we have a significant market share in the USA and we have numerous registrations going on all over the world. We also are specialized in dental research, development and distribution of medical devices.
We are one of the world’s leading manufacturers of dental anesthetics.
PRODUCTS
We are specialized in the production of dental anesthetics using aseptic technique and we work on a constant process of scouting the best medical devices for the dental sector, for which we follow directly the patent aspect, the industrialization and the commercialization, in collaboration with universities and research institutions.
OUR MILESTONES
1948
The Lepetit Group founded the pharmaceutical chemical company Pierrel, dedicated to the production of antibiotics and vitamins. The name comes from the sequence pronunciation of the initials of "Prodotti Roberto Lepetit".
1975
Starts the production of pharmaceutical specialties and medical devices.
1985
The production of local-regional anesthetics in vials and bottles is started. We are the first in Italy to produce anesthetics in cartriges.
1985-1990
Our Research and Development department in Capua develops the formula of toothpaste AZ, a Pierrel product that is very successful thanks to the frequent advertising on national television networks. In these years we are engaged in the production of food supplements (Gimille, Gravigen, Generman) and shampoo (Diesse).
1990
Pierrel sells its brad AZ to Procter & Gamble
1995
Astrazeneca becomes the main customer of the production site.
1999
Dentsply chooses our Capua site for the production of dental anesthetics for Europe, UK and Australia markets
2006
We are landing on the first list (MTA) of Borsa Italiana today called Euronext Milan.
2009
Our production site obtains the FDA (Food and Drug Administration) authorization.
2011
Under the Pierrel brand, we start the registration and marketing of dental anaesthetics. Orabloc is launched on the American market
2018
It is the year of the launch in the USA, Canada, UK and Italy of the medical device Goccles.
2019
Works begins on the production site to increase the production capacity.
2021
Unveiling of the new Inspection and Labelling department.
2021
From the brand Orabloc comes a new medical device, Orabloc Needlestick Safety System.
2022
Orabloc dental Needles are distributed in the U.S.
AWARDS AND CERTIFICATIONS
